Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"September 29, 2026 4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . “
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: 2.3 million cancers diagnosed worldwide in 2024 \u2014 12% of all cases \u2014 were attributable to infections. Greater access to vaccination, screening and treatment can reduce the burden of infection-related cancers. More than 2 million new cancers diagnosed worldwide in 2024 could be attributable to infections, according to study findings. This equates to about one of every eight cases.
Data derived from Rumgay H, et al. Lancet Oncol. 2026; 10.1016\/S1470-2045(26)00307-4.
Harriet Rumgay \u201cWhile this burden is enormous, it is also largely preventable,\u201d lead author Harriet Rumgay, PhD, an epidemiologist in the International Agency for Research on Cancer\u2019s (IARC) cancer surveillance branch, told Healio. \u201cWe already have effective tools and public health strategies that can prevent many infection-related cancers, including vaccination, screening, testing and treatment programs. Our findings reinforce the message that preventing infections is critical to preventing cancer globally. Expanding access to effective interventions and ensuring they are implemented equitably could dramatically reduce the global burden of cancer.\u201d Contemporary assessment An estimated 20.6 million new cancers are expected to be diagnosed worldwide this year, and that number will rise to 35 million in 2050, according to WHO projections. As Healio previously reported, an analysis released earlier this year showed infections represent the second leading avoidable cause of cancer worldwide behind only tobacco. Infections are the leading modifiable risk factor for cancer among women in 141 countries and among men in 58 countries, according to study background. The IARC has classified 13 infectious agents \u2014 nine viruses, three parasites and one bacterium \u2014 as group 1 carcinogens, meaning sufficient evidence exists that they cause cancer in humans. The IARC last published data about the impact of infections on the global cancer burden in 2018. Since then, strong evidence has established additional cancer-causing infections \u2014 such as HIV and Merkel cell polyomavirus \u2014 and identified new cancer types associated with well-established carcinogenic infections, Rumgay said. \u201cThis new evidence made it important to revisit and update the global estimates with the most comprehensive and contemporary assessment,\u201d she said. \u2018Striking\u2019 findings Rumgay and colleagues used Global Cancer Observatory\u2019s Cancer Today database to estimate absolute numbers, population-attributable fractions (PAF) and age-standardized incidence rates (ASIR) of new cancer cases attributable to infectious agents classified as group 1 carcinogens. These included HPV, hepatitis B and C viruses, Helicobacter pylori, Epstein-Barr virus, HIV and Merkel cell polyomavirus, among others. Researchers determined 2.3 million new cancers in 2024 \u2014 approximately one in eight cases \u2014 had been attributable to infections. Five infectious agents accounted for nearly all infection-related cancers: H. pylori (absolute, n = 760,000; PAF = 4%), HPV (absolute, n = 750,000; PAF = 4%), HBV (absolute, n = 360,000; PAF = 2%); Epstein-Barr virus (absolute, n = 260,000; PAF = 1%) and HCV (absolute, n = 160,000; PAF < 1%). Rumgay described the cancer burden attributable to Epstein-Barr virus as one of the \u201cmost striking\u201d findings. The role of Epstein-Barr virus \u2014 previously linked to nasopharyngeal cancer and lymphoma \u2014proved larger than expected due to incorporation of new evidence that showed it also has a causal role in gastric cancer, Rumgay said. The ASIR for all infections combined reached 22.7 cancer cases per 100,000 person-years. Analysis by infection type revealed the highest ASIRs, given as cases per 100,000 person-years, for HPV (7.7), H. pylori (6.9), HBV (3.4), Epstein-Barr virus (2.6), HCV (1.5) and Kaposi\u2019s sarcoma-associated herpesvirus (0.4). More than three-quarters (77%) of infection-related cancers occurred in low- or middle-income countries. Analyses by region showed the greatest burden of infection-attributable cancers in eastern Asia, which accounted for 42% of all infection-related cancers worldwide. The 990,000 absolute cases in this region \u2014 driven largely by H. pylori and HBV \u2014 equated to a PAF of 15% and an ASIR of 31.9 cases per 100,000 person-years. Other regions that accounted for considerable shares of the global burden included sub-Saharan Africa (PAF, 25%; ASIR, 28.5), Central and Eastern Europe (PAF, 10%; ASIR, 24.3) and southeastern Asia (PAF, 16%; ASIR, 23.1). Regions with the lowest PAF included northern Europe (4%), as well as western Europe, North America and Oceania (5% each). Regions with the lowest ASIRs included south-central Asia (13.3), western Asia (14.1), northern Europe (14.1), western Europe (15) and North America (15.8). Analyses that examined links between specific infections and cancer types revealed the strongest associations between H. pylori and gastric cancer; HPV and cervix cancer; HBV\/HCV and hepatocellular carcinoma; and Epstein-Barr virus and nasopharyngeal cancer. \u2018Global health equity issue\u2019 A majority of infection-related cancers can be prevented through vaccination, testing, screening or preventive strategies. However, these interventions are underutilized in many regions due to persistent health system, political and financial barriers, study authors wrote. Multifaceted strategies are needed to reduce the global burden of these malignancies, Rumgay said. \u201cFirst, we need greater implementation of \u2014 and equitable access to \u2014 prevention tools that are already proven to reduce cancer risk,\u201d she said. Key efforts include vaccination against HBV and HPV; testing and treatment for H. pylori, HIV, and HBV and HCV; and screening programs that prevent HPV-driven cervical cancer, Rumgay said. \u201cSecond, we need continued investment in research and development for infections where effective prevention tools do not yet exist,\u201d Rumgay added. \u201cA major priority is the development of vaccines against Epstein-Barr virus, which causes several cancers and has also been linked to multiple sclerosis. We also need to develop new tools to prevent infection with Kaposi sarcoma-associated herpesvirus [KSHV], particularly because the burden of KSHV-related cancers falls disproportionately on resource-limited countries in sub-Saharan Africa.\u201d Improved access to vaccination, screening and treatment<\/p>\n","protected":false},"author":1,"featured_media":3843,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3842","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/3842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3842"}],"version-history":[{"count":0,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/3842\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/media\/3843"}],"wp:attachment":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"hemonc](\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hot.svg?la=en&h=24&w=141&hash=2F86D471C8514C0E334E329AA799E8B4\")
\n <\/div>\n<\/p><\/div>\n<\/p><\/div>\n